Concepedia

Noritaka Tanaka

NT

Statistics

Publications

9

Citations

797

H-Index

9

Active since

1974

Affiliations

The University of Tokyo(Current)

Keio University

Japanese Foundation For Cancer Research

Massachusetts General Hospital

Harvard University

Noritaka Tanaka is an author at The University of Tokyo specializing in medicine, cancer research, and cell biology.

ORCID

Top concepts

Publications per year

1974–2024

9

Publications

9

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

Noritaka Tanaka, Chendi Li, Meagan B. Ryan et al. · Cancer Discovery · 2021 · 475 citations · Full text

Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype.

Tomoki Yamatsuji, Takashi Okamoto, Shuji Takeda et al. · The EMBO Journal · 1996 · 113 citations

, , +10

<i>APC</i> Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer

Noritaka Tanaka, Tetsuo Mashima, Anna Mizutani et al. · Molecular Cancer Therapeutics · 2017 · 81 citations

Sotorasib Is a Pan- <i>RAS</i> G12C Inhibitor Capable of Driving Clinical Response in <i>NRAS</i> G12C Cancers

Douglas A. Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz et al. · Cancer Discovery · 2024 · 38 citations · Full text

mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer

Tetsuo Mashima, Yoko Taneda, Myung-Kyu Jang et al. · Oncotarget · 2017 · 29 citations · Full text

1–5 of 9